Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Heska Corp (HSKA) USD0.01

Sell:$200.12 Buy:$204.98 Change: $2.52 (1.22%)
NASDAQ:1.59%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$200.12
Buy:$204.98
Change: $2.52 (1.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$200.12
Buy:$204.98
Change: $2.52 (1.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.

Contact details

Address:
3760 Rocky Mountain Ave
LOVELAND
80538-7084
United States
Telephone:
+1 (970) 4937272
Website:
https://www.heska.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HSKA
ISIN:
US42805E3062
Market cap:
$1.86 billion
Shares in issue:
9.45 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Scott Humphrey
    Independent Chairman of the Board
  • Kevin Wilson
    President, Chief Executive Officer, Director
  • Catherine Grassman
    Chief Financial Officer, Executive Vice President
  • Nancy Wisnewski
    Chief Operating Officer, Executive Vice President
  • Christopher Sveen
    Executive Vice President, Chief Administrative Officer and General Counsel, Heska and President, Diamond Animal Health
  • Jason Aroesty
    Executive Vice President - International Diagnostics
  • Steven Eyl
    Executive Vice President, Chief Commercial Officer, Heska and President, scil animal care

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.